Synergy CHC (SNYR) Competitors $2.46 -0.23 (-8.55%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNYR vs. ANEB, TCRX, VIRI, IRD, CGTX, ATYR, IPA, ADAG, CRDL, and ATRAShould you be buying Synergy CHC stock or one of its competitors? The main competitors of Synergy CHC include Anebulo Pharmaceuticals (ANEB), TScan Therapeutics (TCRX), Virios Therapeutics (VIRI), Opus Genetics (IRD), Cognition Therapeutics (CGTX), aTyr Pharma (ATYR), ImmunoPrecise Antibodies (IPA), Adagene (ADAG), Cardiol Therapeutics (CRDL), and Atara Biotherapeutics (ATRA). These companies are all part of the "pharmaceutical products" industry. Synergy CHC vs. Its Competitors Anebulo Pharmaceuticals TScan Therapeutics Virios Therapeutics Opus Genetics Cognition Therapeutics aTyr Pharma ImmunoPrecise Antibodies Adagene Cardiol Therapeutics Atara Biotherapeutics Anebulo Pharmaceuticals (NASDAQ:ANEB) and Synergy CHC (NASDAQ:SNYR) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends. Does the media favor ANEB or SNYR? In the previous week, Synergy CHC had 1 more articles in the media than Anebulo Pharmaceuticals. MarketBeat recorded 4 mentions for Synergy CHC and 3 mentions for Anebulo Pharmaceuticals. Anebulo Pharmaceuticals' average media sentiment score of 0.95 beat Synergy CHC's score of 0.67 indicating that Anebulo Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anebulo Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Synergy CHC 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals believe in ANEB or SNYR? 28.4% of Anebulo Pharmaceuticals shares are owned by institutional investors. 80.6% of Anebulo Pharmaceuticals shares are owned by company insiders. Comparatively, 56.6% of Synergy CHC shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has better valuation & earnings, ANEB or SNYR? Synergy CHC has higher revenue and earnings than Anebulo Pharmaceuticals. Anebulo Pharmaceuticals is trading at a lower price-to-earnings ratio than Synergy CHC, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnebulo PharmaceuticalsN/AN/A-$8.20M-$0.26-9.38Synergy CHC$34.83M0.67$2.12M$0.386.47 Is ANEB or SNYR more profitable? Synergy CHC has a net margin of 10.02% compared to Anebulo Pharmaceuticals' net margin of 0.00%. Synergy CHC's return on equity of -18.56% beat Anebulo Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Anebulo PharmaceuticalsN/A -90.11% -84.53% Synergy CHC 10.02%-18.56%20.28% Do analysts rate ANEB or SNYR? Anebulo Pharmaceuticals presently has a consensus price target of $5.50, indicating a potential upside of 125.41%. Synergy CHC has a consensus price target of $10.00, indicating a potential upside of 306.50%. Given Synergy CHC's stronger consensus rating and higher probable upside, analysts clearly believe Synergy CHC is more favorable than Anebulo Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anebulo Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Synergy CHC 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 SummarySynergy CHC beats Anebulo Pharmaceuticals on 11 of the 14 factors compared between the two stocks. Get Synergy CHC News Delivered to You Automatically Sign up to receive the latest news and ratings for SNYR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNYR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNYR vs. The Competition Export to ExcelMetricSynergy CHCCONS PD IndustryStaples SectorNASDAQ ExchangeMarket Cap$25.40M$32.10B$15.67B$10.39BDividend YieldN/A2.66%3.16%4.64%P/E Ratio6.4738.0717.3526.11Price / Sales0.671.8247.74124.93Price / Cash10.1116.2914.6661.24Price / Book-1.298.137.286.30Net Income$2.12M$1.23B$672.25M$271.03M7 Day Performance3.36%-3.34%-0.59%-0.15%1 Month Performance-15.75%-6.32%2.15%6.41%1 Year PerformanceN/A16.09%-2.55%28.81% Synergy CHC Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNYRSynergy CHC3.9736 of 5 stars$2.46-8.6%$10.00+306.5%N/A$25.40M$34.83M6.4740Gap DownANEBAnebulo Pharmaceuticals2.241 of 5 stars$2.45-1.2%$5.50+124.5%+17.2%$101.89MN/A-9.424News CoverageTCRXTScan Therapeutics3.1186 of 5 stars$1.80+1.1%$7.80+333.3%-63.9%$101.01M$6.96M-1.65100VIRIVirios Therapeutics0.2264 of 5 stars$5.18+3.4%$5.00-3.5%+2,548.7%$99.76MN/A-19.195IRDOpus Genetics2.5044 of 5 stars$1.66-2.9%$7.33+341.8%N/A$99.45M$10.99M-0.8614Positive NewsCGTXCognition Therapeutics2.8114 of 5 stars$1.34-6.3%$2.83+111.4%+176.5%$98.52MN/A-2.0020ATYRaTyr Pharma2.4971 of 5 stars$0.99-5.7%$23.25+2,248.2%-45.3%$97.02M$230K-1.2453High Trading VolumeIPAImmunoPrecise Antibodies2.3568 of 5 stars$2.10+8.5%$4.00+90.9%+235.2%$96.68M$17.59M-3.0880Gap UpADAGAdagene2.8061 of 5 stars$2.05+2.0%$7.00+241.5%-9.0%$96.62M$100K0.00260Positive NewsCRDLCardiol Therapeutics2.8027 of 5 stars$1.09-2.7%$8.00+633.9%-50.5%$96.26MN/A-3.2120Positive NewsAnalyst RevisionHigh Trading VolumeATRAAtara Biotherapeutics4.5813 of 5 stars$12.97+5.4%$21.00+61.9%+88.9%$91.05M$128.94M-30.16330News CoveragePositive News Related Companies and Tools Related Companies Anebulo Pharmaceuticals Competitors TScan Therapeutics Competitors Virios Therapeutics Competitors Opus Genetics Competitors Cognition Therapeutics Competitors aTyr Pharma Competitors ImmunoPrecise Antibodies Competitors Adagene Competitors Cardiol Therapeutics Competitors Atara Biotherapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNYR) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synergy CHC Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Synergy CHC With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNYR Stock Alerts